Effizientes MRSA-Management

[1]  M. Postma,et al.  Modelling the Costs and Effects of Selective and Universal Hospital Admission Screening for Methicillin-Resistant Staphylococcus aureus , 2011, PloS one.

[2]  N. Olchanski,et al.  Assessment of the Influence of Test Characteristics on the Clinical and Cost Impacts of Methicillin-Resistant Staphylococcus aureus Screening Programs in US Hospitals , 2011, Infection Control & Hospital Epidemiology.

[3]  A. Friedrich,et al.  Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  Kenneth J. Smith,et al.  Screening cardiac surgery patients for MRSA: an economic computer model. , 2010, The American journal of managed care.

[5]  Kenneth J. Smith,et al.  Universal Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance for Adults at Hospital Admission: An Economic Model and Analysis , 2010, Infection Control & Hospital Epidemiology.

[6]  G. La Torre,et al.  Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. , 2009, The Lancet. Infectious diseases.

[7]  L. Mermel,et al.  Are There Differences in Hospital Cost Between Patients With Nosocomial Methicillin-Resistant Staphylococcus aureus Bloodstream Infection and Those With Methicillin-Susceptible S. aureus Bloodstream Infection? , 2009, Infection Control & Hospital Epidemiology.

[8]  K. Mühlemann,et al.  Rapid Screening for Carriage of Methicillin-Resistant Staphylococcus aureus by PCR and Associated Costs , 2008, Journal of Clinical Microbiology.

[9]  A. Mellmann,et al.  Evidence for cost reduction based on pre-admission MRSA screening in general surgery. , 2008, International journal of hygiene and environmental health.

[10]  C. Masuet,et al.  Comparative Cost of Selective Screening To Prevent Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA), Compared With the Attributable Costs of MRSA Infection , 2006, Infection Control & Hospital Epidemiology.

[11]  P. Gastmeier,et al.  [Control of methicillin-resistant S. aureus by active surveillance. Results of a workshop held by the Deutsche Gesellschaft für Hygiene und Mikrobiologie]. , 2006, Der Anaesthesist.

[12]  Y. Tabak,et al.  Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia , 2006, Critical care.

[13]  G. Bernard,et al.  Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome , 2006, Critical care.

[14]  S. Suerbaum,et al.  Prävention von Methicillin-resistentem S. aureus durch Screeninguntersuchungen , 2006, Der Anaesthesist.

[15]  T. West,et al.  Effect of Targeted Surveillance for Control of Methicillin-Resistant Staphylococcus aureus in a Community Hospital System , 2006, Infection Control & Hospital Epidemiology.

[16]  S. Swidsinski,et al.  Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  K. Anstrom,et al.  Costs and Outcomes Among Hemodialysis-Dependent Patients With Methicillin-Resistant or Methicillin-Susceptible Staphylococcus aureus Bacteremia , 2005, Infection Control & Hospital Epidemiology.

[18]  S. Cosgrove,et al.  The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges , 2005, Infection Control & Hospital Epidemiology.

[19]  R. Schnettler,et al.  Additional Costs for Preventing the Spread of Methicillin-Resistant Staphylococcus aureus and a Strategy for Reducing These Costs on a Surgical Ward , 2003, Infection Control & Hospital Epidemiology.

[20]  Carlene A. Muto,et al.  SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus , 2003, Infection Control & Hospital Epidemiology.

[21]  S. Cosgrove,et al.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  S. Chevret,et al.  Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. , 2003, Archives of internal medicine.

[23]  A. Troelstra,et al.  Costs Associated with a Strict Policy to Eradicate Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-Year Survey , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[24]  M. Whitby,et al.  Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysis , 2001, The Medical journal of Australia.

[25]  C. Brun-Buisson,et al.  Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. , 1999, JAMA.

[26]  M. Louie,et al.  Screening High-Risk Patients for Methicillin-Resistant Staphylococcus Aureus on Admission to the Hospital Is It Cost Effective? , 1999, Infection Control & Hospital Epidemiology.

[27]  W. Jarvis,et al.  Selected Aspects of the Socioeconomic Impact of Nosocomial Infections: Morbidity, Mortality, Cost, and Prevention , 1996, Infection Control & Hospital Epidemiology.

[28]  G. A. Stott,et al.  Control of Methicillin-Resistant Staphylococcus aureus at a University Hospital: One Decade Later , 1995, Infection Control & Hospital Epidemiology.